Luxembourg Cancer Institute Launches Precision Oncology Study

Oct 29, 2018

NEW YORK (GenomeWeb) — Luxembourg's Institut National du Cancer (INC) announced today that it has begun an initiative to evaluate the use of molecular diagnostics in cancer treatment.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Menu

Luxembourg Cancer Institute Launches Precision Oncology Study

To read the full story....

Breaking News

Japan's National Cancer Center Adopts Qiagen Bioinformatics Platform for Precision Med Program

Roche's Rozlytrek Nets Japanese Approval in NTRK-Positive Pan Cancer Indication

European Commission Approves Lynparza for Advanced Ovarian Cancer With BRCA Mutations

FDA Approves Expanded Use of Agilent CDx for Keytruda in Head and Neck Cancer

Multi-Gene Panel Testing Finds Pathogenic Variant Carriers Missed Under Current Testing Guidelines

Saga Diagnostics Raises $4.2M

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

What's Popular?

Next-Generation Sequencing of Pediatric Cancer Patients Could Transform Treatment Paradigms

Wake Forest Researchers Learn From Patient Data in Offering Precision Oncology Broadly

ASCO Data Pushes Boundaries for Genomic Testing in Localized Breast Cancer

Japan's National Cancer Center Adopts Qiagen Bioinformatics Platform for Precision Med Program

Roche's Rozlytrek Nets Japanese Approval in NTRK-Positive Pan Cancer Indication

Sponsorships